Latest News
Conference Coverage
Antidepressants ‘don’t blunt’ semaglutide and weight loss
“Semaglutide 2.4 mg provides an effective treatment option for weight management, regardless of antidepressant use at baseline.”
Latest News
Taking a new obesity drug and birth control pills? Be careful
“It [the warning] was in the product insert, but clinically speaking, I don’t know if it was at the top of providers’ minds when they were...
Latest News
Prior authorization software: Saves time but hurdles remain
The automation works, but the software can be costly and may not work for all practices.
Latest News
Docs weigh in on insurance coverage for obesity medications
“We would not see the spate of coverage restrictions if we were talking about heart disease or cancer; insurers can get away with this because...
Latest News
Testosterone replacement benefits men with type 2 diabetes
Prior data from Dr. Jones' group showed that about 40% of men with type 2 diabetes have symptomatic testosterone deficiency.
From the Journals
Scientists find the ‘on’ switch for energy-burning brown fat
Activating brown fat could trigger “signals that help coordinate whole-body energy metabolism.”
Conference Coverage
Fractures beget fractures at any age
From a person’s 20s to their 80s, the increased risk of fracture after a prior fracture may not be significantly different.
Conference Coverage
Greater fracture risk reduction seen with denosumab vs. zoledronic acid in postmenopausal women
The analysis took extra pains to remove bias through data that might be linked to potential confounders but could not reasonably be attributed to...
From the Journals
Metformin, weight management to stop type 2 diabetes in kids
“Weight stabilization and metformin therapy could be important interventions for diabetes prevention in children.”
Conference Coverage
New ‘twincretin’ pemvidutide: Another option for obesity
“We need to look at the person holistically and at other aspects of cardiometabolic health and treat in a personalized way and choose treatments...
Conference Coverage
Metabolic effects of estetrol are promising in postmenopausal women
Preliminary findings suggest estetrol continues to hold potential for becoming an additional option in treating menopause symptoms.